HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine A Flynn Selected Research

A 419259

1/2022A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine A Flynn Research Topics

Disease

13Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 01/2020
2Lymphoma (Lymphomas)
01/2022 - 01/2020
2Plasmablastic Lymphoma
11/2021 - 10/2021
1Bone Marrow Diseases (Bone Marrow Disease)
10/2021

Drug/Important Bio-Agent (IBA)

6ibrutinibIBA
01/2022 - 06/2020
2Immunoglobulin M (IgM)IBA
10/2021 - 01/2020
2Rituximab (Mabthera)FDA Link
01/2020 - 01/2020
1A 419259IBA
01/2022
1venetoclaxIBA
01/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2022
1src-Family KinasesIBA
01/2022
1Hemoglobins (Hemoglobin)IBA
10/2021
1ulocuplumabIBA
10/2021
1pembrolizumabIBA
10/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1daratumumabIBA
10/2020
1ixazomibIBA
01/2020
1Proteasome InhibitorsIBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020

Therapy/Procedure

2Therapeutics
06/2020 - 01/2020